About Medrep Pharma Private Limited
Data last updated:
Medrep Pharma Private Limited is a private limited company based in Noida Authority Complex, Uttar Pradesh, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 14 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U52609UP2017PTC090408. Its GSTIN is 09AAKCM8205G1ZB (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anish Kumar Singh and Sanjiv Meena Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 41A Shop No – 14 Sector – 17, Noida Authority Complex, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.5 Lakh, a decline of 70% compared to the previous year. For the same year it recorded a net loss of ₹20,771 (net margin -8.3%) and EBITDA of -₹8,194 (EBITDA margin -3.3%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 7% over five years.
As per MCA filings, the company has open charges of ₹1 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medreppharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressA – 41A Shop No – 14 Sector – 17, Noida Authority Complex, Uttar Pradesh, India – 201301
- IndustryHealthcare, Hospitals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medrep Pharma Private Limited
The main business activity of Medrep Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Medrep Pharma Private Limited
Medrep Pharma Private Limited is audited by GOYAL SHARMA & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GOYAL SHARMA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Medrep Pharma Private Limited
Medrep Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anish Kumar Singh | Director | 14 Feb 2017 | 9 Years 7 Months | Current |
| Sanjiv Meena Kumar | Director | 14 Feb 2017 | 9 Years 7 Months | Current |
Financials of Medrep Pharma Private Limited FY 2025 filings available
Medrep Pharma Private Limited reported revenue of ₹2.5 Lakh (down 70% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Medrep Pharma Private Limited
Revenue fell 70% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA fell 127% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medrep Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹8,194 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹20,771 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medrep Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -8.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medrep Pharma are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Medrep Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medrep Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jul 2020 | Indian Overseas Bank | ₹1 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Medrep Pharma Private Limited
Employment history and EPFO contributions of people linked to Medrep Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Medrep Pharma Private Limited
Medrep Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCM8205G1ZB | Uttar Pradesh | Active | 31 Oct 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Medrep Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medrep Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medrep Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medrep Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Medrep Pharma Private Limited
Frequently Asked Questions about Medrep Pharma Private Limited
Medrep Pharma is an active private limited company based in Noida Authority Complex, Uttar Pradesh, India. The company works in hospitals, within the healthcare industry. It was incorporated on 14 February 2017 (9+ years old) and is registered under CIN U52609UP2017PTC090408.
Medrep Pharma reported revenue of ₹2.5 Lakh for FY 2025 (down 70% YoY).
Medrep Pharma has 2 current directors:
- Anish Kumar Singh - Director
- Sanjiv Meena Kumar - Director
Medrep Pharma reported a net loss of ₹20,771 (net margin -8.3%) and EBITDA of -₹8,194 (EBITDA margin -3.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Medrep Pharma is -11% over three years and 7% over five years. In the latest year (FY 2025) revenue fell 70%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Medrep Pharma is 09AAKCM8205G1ZB, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Medrep Pharma is U52609UP2017PTC090408. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medrep Pharma was incorporated on 14 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
Medrep Pharma can be reached through the website medreppharma.com. Its registered office is in Noida Authority Complex, Uttar Pradesh, India.